Clinical Trial Update: An Open-label, Single-dose Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Brodalumab in Pediatric Subjects [Phase 4]

View source ↗

Summary

An open-label, single-dose Phase 4 study to evaluate safety, tolerability, and pharmacokinetics of brodalumab in pediatric subjects with psoriasis. The study st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• brodalumab (brodalumab)

Snippet

Sponsor: Bausch Health Americas, Inc. | Conditions: Psoriasis | Phase 4 | Status: ACTIVE_NOT_RECRUITING